BridgeBio 药 BBIO
$74.29 +$0.02 (+0.03%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $74.36 +0.09%
开盘$74.21
昨收$74.27
当日区间$73.19 – $75.70
成交量3.16M
市值$14.47B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$243.68M+120.4% YoY
营业利润-$107.08M+19.8% YoY
净利润-$155.89M+15.2% YoY
摊薄每股收益-$0.78+17.9% YoY
自由现金流-$71.54M+16.6% YoY
经营现金流-$71.10M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率94.4%
营业利润率-67.0%
净利率-97.0%
资产收益率-60.2%
流动比率1.23
负债/资产比率305.9%
现金及投资$720.16M
总负债$2.49B
净现金（净负债）-$1.77B
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $243.68M | $194.52M | $502.08M | $154.18M | $120.70M |
| 营业总收入 | $243.68M | $194.52M | $502.08M | $154.18M | $120.70M |
| 营业成本 | $15.05M | $9.94M | $20.96M | $8.11M | $6.56M |
| 毛利润 | $228.63M | $184.58M | $481.11M | $146.07M | $114.14M |
| 营业费用 | $335.71M | $290.53M | $983.18M | $274.50M | $250.50M |
| 销售及管理费用 | $186.26M | $163.90M | $531.23M | $158.09M | $137.62M |
| 研发费用 | $149.45M | $126.64M | $451.95M | $116.42M | $112.87M |
| 营业利润 | -$107.08M | -$105.96M | -$502.06M | -$128.43M | -$136.36M |
| 非经营性利息净收入（支出） | -$47.96M | -$46.57M | -$158.39M | -$45.98M | -$41.91M |
| 非经营性利息收入 | $6.66M | $6.25M | $19.85M | $4.33M | $6.24M |
| 非经营性利息支出 | $54.62M | $52.82M | $178.24M | $50.31M | $48.15M |
| 其他收入（支出） | -$848,000.00 | -$14.03M | -$72.05M | -$20.34M | -$8.21M |
| 权益法投资收益 | -$6.44M | -$18.28M | -$72.61M | -$21.03M | -$15.83M |
| 特殊收益（费用） | $5.59M | $0.00 | -$42.50M | -$42.37M | $7.62M |
| -减：重组及并购费用 | $0.00 | $0.00 | $21.35M | $11.13M | $8.84M |
| -固定资产出售收益 | $5.59M | – | – | – | $16.46M |
| 税前利润 | -$155.89M | -$166.56M | -$732.50M | -$194.76M | -$186.48M |
| 税费 | $0.00 | – | $435,000.00 | -$120,000.00 | -$1.55M |
| 净利润 | -$155.89M | -$166.56M | -$732.94M | -$194.64M | -$184.94M |
| 持续经营利润 | -$155.89M | -$166.56M | -$732.94M | -$194.64M | -$184.94M |
| 少数股东权益 | -$3.68M | -$2.51M | -$8.01M | -$1.77M | -$2.19M |
| 归属母公司净利润 | -$152.22M | -$164.04M | -$724.93M | -$192.86M | -$182.74M |
| 归属普通股股东净利润 | -$152.22M | -$164.04M | -$724.93M | -$192.86M | -$182.74M |
| 基本每股收益 | -$0.78 | -$0.84 | -$3.78 | -$1.00 | -$0.95 |
| 摊薄每股收益 | -$0.78 | -$0.84 | -$3.78 | -$1.00 | -$0.95 |
| 其他非经营性收入（支出） | – | $4.25M | $43.06M | – | – |
| -减：资本性资产减值 | – | – | $0.00 | $0.00 | $0.00 |
| -减：其他特殊支出 | – | – | $21.16M | $0.00 | – |
| -业务出售收益 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.22B | $1.37B | $936.03M | $936.03M | $998.25M |
| 流动资产合计 | $1.09B | $1.24B | $797.75M | $797.75M | $839.38M |
| 现金及现金等价物与短期投资 | $720.16M | $940.19M | $587.48M | $587.48M | $645.94M |
| -现金及现金等价物 | $677.91M | $879.89M | $570.12M | $570.12M | $642.95M |
| -短期投资 | $42.25M | $60.30M | $17.36M | $17.36M | $2.99M |
| 应收款 | $254.48M | $205.23M | $139.44M | $139.44M | $116.52M |
| -应收账款 | $254.48M | $205.23M | $139.44M | $139.44M | $116.52M |
| 存货 | $52.84M | $32.98M | $26.75M | $26.75M | $24.53M |
| 其他流动资产 | $65.65M | $62.91M | $44.07M | $44.07M | $52.40M |
| 非流动资产合计 | $124.16M | $129.68M | $138.28M | $138.28M | $158.87M |
| 固定资产净值 | $22.31M | $22.17M | $13.52M | $13.52M | $12.38M |
| -固定资产原值 | $22.31M | $22.17M | $13.52M | $13.52M | $12.38M |
| 投资及预付款 | $55.10M | $61.53M | $79.97M | $79.97M | $92.17M |
| -长期股权投资 | $55.10M | $61.53M | $79.97M | $79.97M | $92.17M |
| 商誉及其他无形资产 | $26.64M | $27.36M | $28.08M | $28.08M | $28.80M |
| 其他非流动资产 | $20.12M | $18.62M | $16.71M | $16.71M | $25.52M |
| 负债合计 | $3.72B | $3.64B | $3.01B | $3.01B | $2.92B |
| 流动负债合计 | $890.65M | $816.37M | $287.97M | $287.97M | $216.60M |
| 应付款 | $27.20M | $29.06M | $36.23M | $36.23M | $18.70M |
| -应付账款 | $27.20M | $29.06M | $36.23M | $36.23M | $18.70M |
| 一年内应计费用 | $227.37M | $168.45M | $150.44M | $150.44M | $118.76M |
| 短期债务及融资租赁负债 | $551.27M | $551.92M | $6.19M | $6.19M | $5.29M |
| -一年内到期债务 | $547.96M | $547.48M | – | – | – |
| -一年内到期融资租赁负债 | $3.32M | $4.44M | $6.19M | $6.19M | $5.29M |
| 一年内递延负债 | $34.83M | $27.60M | $18.41M | $18.41M | $9.09M |
| 非流动负债合计 | $2.83B | $2.82B | $2.72B | $2.72B | $2.70B |
| 长期债务及融资租赁负债 | $1.94B | $1.94B | $1.86B | $1.86B | $1.85B |
| -长期债务 | $1.93B | $1.93B | $1.85B | $1.85B | $1.85B |
| -长期融资租赁负债 | $14.97M | $14.22M | $3.81M | $3.81M | $3.43M |
| 一年以上递延负债 | $889.80M | $882.96M | $868.11M | $868.11M | $849.26M |
| 其他非流动负债 | $240,000.00 | $229,000.00 | $244,000.00 | $244,000.00 | $679,000.00 |
| 股东权益合计 | -$2.51B | -$2.27B | -$2.08B | -$2.08B | -$1.92B |
| 股东权益 | -$2.52B | -$2.28B | -$2.09B | -$2.09B | -$1.93B |
| 股本 | $206,000.00 | $204,000.00 | $202,000.00 | $202,000.00 | $200,000.00 |
| -普通股 | $206,000.00 | $204,000.00 | $202,000.00 | $202,000.00 | $200,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.16B | $2.11B | $2.06B | $2.06B | $2.02B |
| 留存收益 | -$4.14B | -$3.99B | -$3.82B | -$3.82B | -$3.63B |
| 减：库存股 | $533.28M | $405.78M | $323.28M | $323.28M | $323.28M |
| 不影响留存收益的损益 | -$7,000.00 | -$8,000.00 | $12,000.00 | $12,000.00 | $2,000.00 |
| 少数股东权益 | $9.32M | $9.49M | $10.03M | $10.03M | $10.34M |
| 其他流动负债 | – | – | – | – | $8.60M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$71.10M | -$197.28M | -$445.91M | -$56.42M | -$109.57M |
| 持续经营经营活动现金流净额 | -$71.10M | -$197.28M | -$445.91M | -$56.42M | -$109.57M |
| 持续经营净利润 | -$155.89M | -$166.56M | -$732.94M | -$194.64M | -$184.94M |
| 持续经营损益 | $6.44M | $18.28M | $84.93M | $31.03M | -$695,000.00 |
| 折旧、折耗与摊销 | $1.05M | $1.19M | $5.43M | $1.44M | $1.40M |
| 其他非现金项目 | $44.90M | $43.16M | $136.01M | $42.81M | $37.87M |
| 营运资金变动 | -$9.29M | -$124.74M | -$51.06M | $49.61M | -$3.93M |
| -应收款变动 | -$49.26M | -$65.78M | -$134.72M | -$22.93M | -$39.65M |
| -存货变动 | -$21.11M | -$7.05M | -$25.31M | -$1.95M | -$6.77M |
| -预付资产变动 | -$1.38M | -$18.85M | -$8.78M | $8.75M | $5.22M |
| -应付账款及应计费用变动 | $19.90M | -$31.65M | $56.79M | $44.15M | $14.74M |
| -其他流动资产变动 | -$1.49M | -$1.80M | $1.11M | $545,000.00 | $742,000.00 |
| -其他流动负债变动 | $45.97M | $2.77M | -$6.55M | -$54.82M | $24.78M |
| -其他营运资金变动 | -$1.92M | -$2.38M | $66.38M | $75.86M | -$2.99M |
| 投资活动现金流净额 | $17.89M | -$42.74M | -$24.49M | -$14.35M | $4.46M |
| 持续经营投资活动现金流净额 | $17.89M | -$42.74M | -$24.49M | -$14.35M | $4.46M |
| 固定资产购置及出售净额 | -$443,000.00 | -$69,000.00 | -$1.10M | -$33,000.00 | -$470,000.00 |
| 无形资产购置及出售净额 | $0.00 | $0.00 | -$8.50M | $0.00 | -$2.40M |
| 投资购置及出售净额 | $18.33M | -$42.67M | -$17.20M | -$14.32M | $5.03M |
| 筹资活动现金流 | -$148.77M | $549.89M | $359.29M | -$2.18M | -$894,000.00 |
| 持续经营筹资活动现金流净额 | -$148.77M | $549.89M | $359.29M | -$2.18M | -$894,000.00 |
| 债务发行及偿还净额 | $0.00 | $632.50M | $116.00M | $0.00 | $0.00 |
| 普通股发行净额 | -$131.77M | -$86.57M | -$62.50M | -$7.43M | -$3.03M |
| 股票期权行使所得 | $5.22M | $28.06M | $34.15M | $13.21M | $8.02M |
| 其他筹资费用净额 | -$22.22M | -$24.09M | $271.65M | -$7.96M | -$5.89M |
| 期末现金余额 | $680.04M | $882.02M | $572.14M | $572.14M | $645.10M |
| 现金净变动 | -$201.98M | $309.88M | -$111.10M | -$72.96M | -$106.00M |
| 期初现金余额 | $882.02M | $572.14M | $683.24M | $645.10M | $751.10M |
| 自由现金流 | -$71.54M | -$197.35M | -$455.50M | -$56.45M | -$112.44M |
| 业务购买及出售净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 BBIO。
登录后参与讨论。